CUFinder

Anthony Moorman

Anthony Moorman

Newcastle University

H-index: 75

Europe-United Kingdom

Contact Anthony Moorman

About Anthony Moorman

Anthony Moorman, With an exceptional h-index of 75 and a recent h-index of 52 (since 2020), a distinguished researcher at Newcastle University, specializes in the field of leukemia genetics, biomarkers, prognostication.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations

Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL

Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL

Diagnostic Utility of Comprehensive RNA-Seq Analysis in Adult B-ALL

Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

Anthony Moorman Information

University

Position

Professor of Genetic Epidemiology

Citations(all)

21964

Citations(since 2020)

8797

Cited By

16901

hIndex(all)

75

hIndex(since 2020)

52

i10Index(all)

163

i10Index(since 2020)

122

Email

University Profile Page

Google Scholar

Anthony Moorman Skills & Research Interests

leukemia genetics

biomarkers

prognostication

Top articles of Anthony Moorman

Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations

EJC Paediatric Oncology

2024/6/1

Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

Leukemia

2024/4/10

Frederik W Van Delft
Frederik W Van Delft

H-Index: 17

John Lunec
John Lunec

H-Index: 26

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study

Blood Advances

2024/3/12

Christine J Harrison
Christine J Harrison

H-Index: 51

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL

Journal of Clinical Oncology

2024/3/10

Aditi Vedi
Aditi Vedi

H-Index: 6

Andrea Malone
Andrea Malone

H-Index: 2

Sanjay Tewari
Sanjay Tewari

H-Index: 5

Indu Thakur
Indu Thakur

H-Index: 6

David O'Connor
David O'Connor

H-Index: 3

Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL

Blood

2024/3/7

Jose Espejo Valle-Inclán
Jose Espejo Valle-Inclán

H-Index: 7

Lucia Conde
Lucia Conde

H-Index: 21

Sunniyat Rahman
Sunniyat Rahman

H-Index: 6

Jack Bartram
Jack Bartram

H-Index: 15

Gary Wright
Gary Wright

H-Index: 9

Christopher Howell
Christopher Howell

H-Index: 0

Diagnostic Utility of Comprehensive RNA-Seq Analysis in Adult B-ALL

Blood

2023/11/2

Anthony Moorman
Anthony Moorman

H-Index: 49

Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia

Leukemia

2023/3

Christine J Harrison
Christine J Harrison

H-Index: 51

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

Cancer Cell International

2023/9/15

Frederik W Van Delft
Frederik W Van Delft

H-Index: 17

John Lunec
John Lunec

H-Index: 26

The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21

Blood

2023/8/24

Lei Shi
Lei Shi

H-Index: 10

Cheng Cheng
Cheng Cheng

H-Index: 13

Matthew Bashton
Matthew Bashton

H-Index: 17

Yiping Fan
Yiping Fan

H-Index: 13

Gang Wu
Gang Wu

H-Index: 34

Christine J Harrison
Christine J Harrison

H-Index: 51

EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy

Blood

2023/2/16

Mignon Loh
Mignon Loh

H-Index: 69

Jack Bartram
Jack Bartram

H-Index: 15

Claudia Paris
Claudia Paris

H-Index: 7

Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia

Blood Advances

2023/8/8

Pip Patrick
Pip Patrick

H-Index: 11

David Jones
David Jones

H-Index: 43

Christine J Harrison
Christine J Harrison

H-Index: 51

Peter Campbell
Peter Campbell

H-Index: 6

Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia

Leukemia & lymphoma

2023/1/2

John Burn
John Burn

H-Index: 1

Michael S Jackson
Michael S Jackson

H-Index: 15

P362: OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION USING REAL-WORLD DATA FROM HARMONY

HemaSphere

2023/8/1

Riley Taiji
Riley Taiji

H-Index: 2

Anthony Moorman
Anthony Moorman

H-Index: 49

Outcomes in patients with relapsed or refractory acute lymphoblastic leukemia receiving hematopoietic cell transplantation using real-world data from harmony.

2023

The clinicogenomic landscape of induction failure in childhood and young adult T-cell acute lymphoblastic leukemia

Journal of Clinical Oncology

2023/4/25

David O'Connor
David O'Connor

H-Index: 3

Lucia Conde
Lucia Conde

H-Index: 21

Sunniyat Rahman
Sunniyat Rahman

H-Index: 6

Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working …

Leukemia

2023/1

Allen Eng Juh Yeoh
Allen Eng Juh Yeoh

H-Index: 30

Christine J Harrison
Christine J Harrison

H-Index: 51

Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre …

The Lancet Haematology

2023/7/1

Andrea Biondi
Andrea Biondi

H-Index: 1

The Prognostic Effect of IKZF1 Deletions in ETV6:: RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia

Hemasphere

2023/5/1

Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL

Blood Advances

2023/12/12

Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform

Leukemia

2023/12

Martin Zimmermann
Martin Zimmermann

H-Index: 11

See List of Professors in Anthony Moorman University(Newcastle University)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine